BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trovato FM, Martines GF, Catalano D, Musumeci G, Pirri C, Trovato GM. Echocardiography and NAFLD (non-alcoholic fatty liver disease). Int J Cardiol. 2016;221:275-279. [PMID: 27404689 DOI: 10.1016/j.ijcard.2016.06.180] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Yong JN, Ng CH, Lee CW, Chan YY, Tang ASP, Teng M, Tan DJH, Lim WH, Quek J, Xiao J, Chin YH, Foo R, Chan M, Lin W, Noureddin M, Siddiqui MS, Muthiah MD, Sanyal A, Chew NWS. Non-alcoholic fatty liver disease association with structural heart, systolic and diastolic dysfunction: a meta-analysis. Hepatol Int 2022. [PMID: 35320497 DOI: 10.1007/s12072-022-10319-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhu XP, Han GC, Chen Q, Zhang ZY, Wang LS, Zhang B. Fatty liver is a sensitive early warning for hypertension and its complication in the Chinese population. Clin Exp Hypertens 2022;:1-7. [PMID: 35129024 DOI: 10.1080/10641963.2022.2029469] [Reference Citation Analysis]
3 Alon L, Corica B, Raparelli V, Cangemi R, Basili S, Proietti M, Romiti GF. Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Prev Cardiol 2021:zwab212. [PMID: 34939092 DOI: 10.1093/eurjpc/zwab212] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
4 Zhou Z, Sang L, Wang J, Song L, Zhu L, Wang Y, Xiao J, Lian Y. Relationships among N,N-dimethylformamide exposure, CYP2E1 and TM6SF2 genes, and non-alcoholic fatty liver disease. Ecotoxicol Environ Saf 2021;228:112986. [PMID: 34794021 DOI: 10.1016/j.ecoenv.2021.112986] [Reference Citation Analysis]
5 Xu J, Cao K, Zhao L, Feng Z, Dong Z, Li J, Liu J. The effects and mechanisms of pomegranate in the prevention and treatment of metabolic syndrome. Tradit Med Mod Med 2020;03:223-37. [DOI: 10.1142/s2575900020300064] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sechi LA, Soardo G, Catena C. Nonalcoholic fatty liver and left ventricular remodelling: now the prospective evidence. J Hypertens 2021;39:864-6. [PMID: 33824256 DOI: 10.1097/HJH.0000000000002750] [Reference Citation Analysis]
7 Ramadan MS, Russo V, Nigro G, Durante-Mangoni E, Zampino R. Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective. J Clin Med 2021;10:1569. [PMID: 33917867 DOI: 10.3390/jcm10081569] [Reference Citation Analysis]
8 Shroff H, VanWagner LB. Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management. Curr Hepatol Rep. 2020;19:315-326. [PMID: 33585157 DOI: 10.1007/s11901-020-00530-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Li X, Heiskanen JS, Ma H, Heianza Y, Guo Y, Kelly TN, He H, Fonseca VA, Chen W, Harville EW, Ruohonen S, Hutri-Kähönen N, Bazzano LA, Raitakari OT, Qi L. Fatty liver index and left ventricular mass: prospective associations from two independent cohorts. J Hypertens 2021;39:961-9. [PMID: 33560053 DOI: 10.1097/HJH.0000000000002716] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen X, Su L, Yang Y, Qv J, Wei T, Cui X, Shao J, Liu S, Xu Z, Zhao B, Miao J. A new activator of esterase D decreases blood cholesterol level through ESD/JAB1/ABCA1 pathway. J Cell Physiol 2021;236:4750-63. [PMID: 33615471 DOI: 10.1002/jcp.30196] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
11 Chiu LS, Pedley A, Massaro JM, Benjamin EJ, Mitchell GF, McManus DD, Aragam J, Vasan RS, Cheng S, Long MT. The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study. Liver Int 2020;40:2445-54. [PMID: 32654390 DOI: 10.1111/liv.14600] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M, Steffen HM. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol 2021;110:921-37. [PMID: 32696080 DOI: 10.1007/s00392-020-01709-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
13 Yu SH. Letter: Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus (Diabetes Metab J 2020;44:267-76). Diabetes Metab J 2020;44:482-3. [PMID: 32613780 DOI: 10.4093/dmj.2020.0123] [Reference Citation Analysis]
14 Roh JH, Park JH, Lee H, Yoon YH, Kim M, Kim YG, Park GM, Lee JH, Seong IW. Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea. BMC Cardiovasc Disord 2020;20:204. [PMID: 32345225 DOI: 10.1186/s12872-020-01444-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
15 Chen HT, Huang HL, Li YQ, Xu HM, Zhou YJ. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view. World J Gastroenterol 2020; 26(16): 1901-1911 [PMID: 32390701 DOI: 10.3748/wjg.v26.i16.1901] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
16 Jha AK, Lata S. Liver transplantation and cardiac illness: Current evidences and future directions. J Hepatobiliary Pancreat Sci 2020;27:225-41. [PMID: 31975575 DOI: 10.1002/jhbp.715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS. Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019;73:948-963. [PMID: 30819364 DOI: 10.1016/j.jacc.2018.11.050] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 40.0] [Reference Citation Analysis]
18 Dong Y, Cui H, Sun L, Wang Y, Li Y, Chang W, Li G, Huang D. Assessment of left ventricular function in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease using three-dimensional speckle-tracking echocardiography. Anatol J Cardiol 2020;23:41-8. [PMID: 31911565 DOI: 10.14744/AnatolJCardiol.2019.66805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 de Freitas Diniz TB, de Jesus RN, Jimenez LS, Pareja JC, Chaim EA, Cazzo E. Non-Alcoholic Fatty Liver Disease Is Associated with Impairment of Ejection Fraction Among Individuals with Obesity Undergoing Bariatric Surgery: Results of a Cross-Sectional Study. Obes Surg 2020;30:456-60. [PMID: 31529394 DOI: 10.1007/s11695-019-04179-7] [Reference Citation Analysis]
20 Dong Y, Li G. Cardiac abnormalities in patients with nonalcoholic fatty liver disease : Insights from auxiliary examinations. Herz 2021;46:158-63. [PMID: 31538216 DOI: 10.1007/s00059-019-04855-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Borges-Canha M, Neves JS, Libânio D, Von-Hafe M, Vale C, Araújo-Martins M, Leite AR, Pimentel-Nunes P, Carvalho D, Leite-Moreira A. Association between nonalcoholic fatty liver disease and cardiac function and structure-a meta-analysis. Endocrine 2019;66:467-76. [PMID: 31482382 DOI: 10.1007/s12020-019-02070-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Anstee QM, Mantovani A, Tilg H, Targher G. Risk of cardiomyopathy and cardiac arrhythmias in patients with nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2018;15:425-439. [PMID: 29713021 DOI: 10.1038/s41575-018-0010-0] [Cited by in Crossref: 118] [Cited by in F6Publishing: 116] [Article Influence: 39.3] [Reference Citation Analysis]
23 Ahmed IA, Mikail MA, Mustafa MR, Ibrahim M, Othman R. Lifestyle interventions for non-alcoholic fatty liver disease. Saudi J Biol Sci 2019;26:1519-24. [PMID: 31762620 DOI: 10.1016/j.sjbs.2018.12.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Saeed WK, Jun DW, Jang K, Ahn SB, Oh JH, Chae YJ, Lee JS, Kang HT. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(48): 5477-5490 [PMID: 30622377 DOI: 10.3748/wjg.v24.i48.5477] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
25 Chung GE, Lee J, Lee H, Kim MK, Yim JY, Choi S, Kim YJ, Yoon J, Kim D. Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction. Atherosclerosis 2018;272:137-44. [DOI: 10.1016/j.atherosclerosis.2018.03.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
26 Trovato FM, Martines GF, Catalano D. Addressing Western dietary pattern in obesity and NAFLD. Nutrire 2018;43. [DOI: 10.1186/s41110-018-0067-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Wójcik-Cichy K, Koślińska-Berkan E, Piekarska A. The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases. Clin Exp Hepatol 2018;4:1-6. [PMID: 29594192 DOI: 10.5114/ceh.2018.73155] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
28 Delvecchio M, Muggeo P, Monteduro M, Lassandro G, Novielli C, Valente F, Salinaro E, Zito A, Ciccone MM, Miniello VL, Santoro N, Giordano P, Faienza MF. Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. European Journal of Endocrinology 2017;176:111-21. [DOI: 10.1530/eje-16-0608] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]